Jason Douglas Maguire

Title: Jason Douglas Maguire: Innovator in Meningococcal Research

Introduction

Jason Douglas Maguire is a notable inventor based in Chesapeake, VA (US). He has made significant contributions to the field of immunology, particularly in the development of compositions aimed at combating Neisseria meningitidis.

Latest Patents

Maguire holds a patent for "Neisseria meningitidis compositions and methods thereof." This patent includes a composition that features a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. The methods described in the patent focus on using this composition to elicit an immune response against both serogroup B strains and non-serogroup B strains. The applications of this invention are directed towards administration in humans, including adults, adolescents, toddlers, and infants.

Career Highlights

Jason Douglas Maguire is currently employed at Pfizer Corporation, where he continues to advance his research in the field of vaccines and immunology. His work is crucial in the ongoing efforts to develop effective treatments and preventive measures against meningococcal diseases.

Collaborations

Maguire has collaborated with esteemed colleagues such as Annaliesa Sybil Anderson and John Lance Perez. Their combined expertise contributes to the innovative research and development efforts at Pfizer Corporation.

Conclusion

Jason Douglas Maguire is a prominent figure in the field of immunology, with a focus on developing effective compositions against Neisseria meningitidis. His contributions are vital for advancing public health and improving vaccine efficacy.